On July 16, 2026, Erica Schwartz attended her confirmation hearing before the Senate Health, Education, Labor, and Pensions Committee. The hearing focused on her nomination to lead the Centers for Disease Control and Prevention (CDC). During the session, Schwartz was questioned about her stance on the previous administration’s decision to halt mRNA vaccine research.
When asked whether she supports the cancellation of mRNA vaccine research initiated by the Trump administration, Schwartz expressed her lack of prior knowledge. She stated, “This is the first time I’m actually hearing about this. As a private citizen, I certainly was not following that.”
This response did little to reassure observers about her potential role as a check on Robert F. Kennedy Jr., raising concerns about her preparedness and effectiveness as CDC leader. Her comments have sparked debate about her capability to manage health policy and oversee critical vaccination programs.